CASI Pharmaceuticals (CASIF) Selling, General & Administrative (2022 - 2025)
CASI Pharmaceuticals (CASIF) Selling, General & Administrative (2022 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
-7.36 Mn |
| 10 |
CASI Pharmaceuticals |
- |
- |
3.69 Mn |
9.56 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
9.56 Mn |
| Sep 30, 2025 |
-4.93 Mn |
| Jun 30, 2025 |
-6.08 Mn |
| Mar 31, 2025 |
-7.70 Mn |
| Dec 31, 2024 |
40.03 Mn |
| Sep 30, 2024 |
-5.70 Mn |
| Jun 30, 2024 |
-5.94 Mn |
| Mar 31, 2024 |
-4.81 Mn |
| Dec 31, 2023 |
6.42 Mn |
| Sep 30, 2023 |
5.52 Mn |
| Jun 30, 2023 |
7.70 Mn |
| Mar 31, 2023 |
5.75 Mn |
| Dec 31, 2022 |
-39.14 Mn |
| Sep 30, 2022 |
4.85 Mn |
| Jun 30, 2022 |
5.52 Mn |
| Mar 31, 2022 |
5.33 Mn |
